Sari Holtz
November 20, 2024
The Israel Clinical Trials Network was launched with the support of the IIA and Ministry of Health.
Tel Aviv, Israel - November 20, 2024 - Yonalink, the leading EHR-to-EDC data streaming provider for clinical trials, today announced the launch of the Israel Clinical Trials Network (ICTN), the country’s first consortium of major hospitals and clinical research organizations (CROs) to boost clinical trials in Israel by global pharmaceutical and medical device companies.
“Given the digitized nature of Israel’s healthcare system, a robust innovation ecosystem and significant government investment in healthtech infrastructures and biotech industries, the country is primed to be a global powerhouse for clinical trial research,” said Shomrat Shurtz, Senior Director, Healthcare Sector Lead - Deputy V.P. Growth Division at Israel Innovation Authority. “Most of the world’s largest pharmaceutical companies already have a presence in Israel and organized cooperation among all stakeholders will ensure that clinical trials can be conducted efficiently at a national level.”
Yonalink, which is spearheading the initiative, has pioneered a solution to address the interoperability challenges facing clinical trials today. The company’s EHR-to-EDC streaming technology automates patient data collection from electronic health records (EHRs), replacing today’s manual data collection processes. By streaming data directly from the EHR to the sponsor’s electronic data capture (EDC) system, Yonalink reduces manual errors, while allowing real-time data oversight which improves trial efficiency and reduces staff burnout.
“Yonalink is proud to have initiated and led this collective effort to make Israel a trailblazer for clinical trial innovation and to drive investment. We see it as imperative to making life-saving drugs more accessible,” said Iddo Peleg, CEO and Co-founder at Yonalink. “Israel is the first country in the world to be connected at a national level for clinical trials, and our technology is powering this. Yonalink enables medical centers and pharma companies to easily stream patient data from one location to another throughout a clinical trial.”
Participating hospitals include Sheba Medical Center, Rabin Medical Center, Soroka Medical Center, Assuta Hospital, Rambam Hospital, and Hadassah Medical Center.
Earlier this year, Yonalink announced the successful completion of the largest EHR-to-EDC live pilot study to date, conducted in partnership with Sheba Medical Center. The results showed that 93% of the requested study data was transferred and that all data was transferred with 100% accuracy, the highest known to date in the industry.
In addition to Israel, Yonalink’s medical center network includes leading research hospitals in France, Spain, and Portugal, with further expansion plans in Norway, the Netherlands, and Italy, expected in 2025. The company’s network of US sites exceeds 6,000 medical centers across the country.
###
About Yonalink
Yonalink equips research teams with the ability to extract up-to-date patient data from any EHR and stream that data into a clinical trial electronic data capture (EDC) system in real time, reducing clinical trial timelines and costs. Headquartered in Boston, Yonalink is bringing new levels of speed, quality, and efficiency to clinical trial operations across the globe, simplifying the complexity of clinical data collection and validation, and enabling true scalability. With over 7,000 medical centers in the Yonalink network, the company’s SaaS platform can stream clinical data from any part of the world, and transfer it to any EDC or clinical data repository. Learn more at www.yonalink.com.